-
-
-
-
-
-
-
Abivax shares surge after report flags continued Eli Lilly takeover interest
-
-
-
-
-
-
-
Biotech Valuations Rise as New Clinical Platforms Show Progress
-
-
-
-
-
-
-
Nektar Therapeutics (NKTR) Strength Attributed to Rumor
-
-
-
-
-
-
-
Lilly and Verve announce expiration of Verve tender offer
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) to acquire Verve Therapeutics (VERV) for $10.50/sh Cash plus CVR
-
-
-
-
-
-
-
Sanofi to acquire Vigil Neuroscience in Alzheimer’s drug play
-
-
-
-
-
-
-
Lilly (LLY) to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

